Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11-C]OMAR in Opioid Use Disorder
NCT05683184Phase 1Recruiting
- Sponsor
- Yale University
- Start
- Mar 2023
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of [11C]OMAR in opioid use disorder (OUD) (2 arms), sponsored by Yale University. Primary endpoint: Cannabinoid Receptor 1 Availability. Started Mar 2023; status: recruiting.
02
Drugs
[11C]OMAR
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05683184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683184.